Type 2 diabetes trials in Türkiye

In Türkiye 66 Also abroad 1247

47 of 66 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Where
Adana, Afyonkarahisar, Ankara, Antalya, Bursa, Edirne, Istanbul, Izmir, Kayseri, Malatya, Zonguldak
Age
18 years and over
People
11,800 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00
Phase 3Not yet taking people in Türkiye
A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise
Where
Adapazarı/Sakarya, Ankara, Bursa, Giresun, Istanbul, Yuregir/Adana
Age
18 years and over
People
200 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07931495 · EU 2026-525470-18-00
Phase 3Not yet taking people in Türkiye
A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease Treated With Once Daily Basal Insulin Alone or in Combination With Metformin, SGLT2i, or Both
Where
Adana, Adapazarı/Turkiye, Afyonkarahisar, Ankara, Gaziantep, Izmir, Kartal/İstanbul, Kayseri, Kocaeli, Yüreğir/ADANA
Age
18 years and over
People
450 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07931547 · EU 2026-525471-13-00
No phaseTaking people
Ultrasound-Guided Thoracolumbar Fascia Injection for Chronic Low Back Pain in Patients With Type 2 Diabetes
Where
Küçükçekmece
Age
18 years to 65 years
People
60
Run by
Hatice Zehra FERHATLAR
See details and how to joinNCT07927530
No phaseTaking people
Effect of Sensory Training on Functional Performance, Balance, Gait in Type 2 Diabetic Individuals With Neuropathy
Where
Van
Age
35 years to 65 years
People
40
Run by
Aylin DEMİR
See details and how to joinNCT06979401
Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Where
Adana, Ankara, Antalya, Istanbul, Izmir, Sariçam
Age
18 years and over
People
1,600 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00
Phase 3Not yet taking people in Türkiye
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Where
Ankara, Antalya, Center, Istanbul
Age
18 years and over
People
500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07776509 · EU 2025-523295-23-00
No phaseTaking people
Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes
Where
Denizli
Age
18 years to 65 years
People
30
Run by
Pamukkale University
See details and how to joinNCT07924436
No phaseNot yet taking people in Türkiye
Comparison of Functional Inspiratory Muscle Training and Combined Exercise Training in Individuals With Type 2 Diabetes
Where
Istanbul
Age
40 years to 65 years
People
39
Run by
İrem Çaylak Yetüt
See details and how to joinNCT07921901
No phaseTaking people
Effect of 4-7-8 Breathing Technique on Pain and Anxiety During Electromyography in Diabetic Neuropathy
Where
Osmaniye
Age
18 years to 70 years
People
100
Run by
Nurgül Gün
See details and how to joinNCT07702175
No phaseTaking people
Perioperative Meditation Music Intervention in Patients With Type 2 Diabetes Undergoing Elective Surgery
Where
Istanbul
Age
40 years to 70 years
People
84
Run by
Istanbul Aydın University
See details and how to joinNCT07770204
Phase 3Not yet taking people in Türkiye
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
Where
Adana, Ankara, Antalya, Diyarbakır, Eskişehir, Istanbul, Kayseri, Kocaeli, Yüreğir
Age
45 years to 64 years
People
3,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00
Phase 3Not yet taking people in Türkiye
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
Where
Ankara, Gaziantep, Istanbul, Konya
Age
18 years and over
People
2,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662109 · EU 2025-523941-81-00
No phaseNot yet taking people in Türkiye
The Effect of Individualized Nursing Interventions on Glycemic Variability and Self-Management in Type 2 Diabetes
Where
Erzurum
Age
18 years to 65 years
People
72
Run by
Ataturk University
See details and how to joinNCT06973395
No phaseTaking people
Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus
Where
Adana, Bakirkoy Istanbul, Basaksehir / Istanbul, Istanbul, Ümraniye / İstanbul
Age
18 years and over
People
270 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06704672
No phaseTaking people
Flaxseed Consumption on Biochemical and Quality of Life in Type 2 Diabetes
Where
Samsun
Age
19 years to 65 years
People
46
Run by
Ondokuz Mayıs University
See details and how to joinNCT06911060
Phase 3Not yet taking people in Türkiye
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Where
Adana, Adapazarı, Ankara, Antalya, Istanbul
Age
18 years and over
People
4,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07667803
No phaseNot yet taking people in Türkiye
Effect of Interactive Video-Based Self-Management Education in Adults With Type 2 Diabetes
Where
Yalova
Age
18 years to 65 years
People
60
Run by
Abant Izzet Baysal University
See details and how to joinNCT07374744
No phaseEnrolling by invitation
AIM-WEIGHT: AI-Guided Microbiome-Targeted Nutritional Intervention for Weight Loss
Where
Istanbul
Age
18 years to 65 years
People
80
Run by
Varol TUNALI
See details and how to joinNCT07736547
No phaseTaking people
The Effectiveness of an Occupation-Based Lifestyle Program in Individuals With Type 2 Diabetes
Where
Ankara
Age
18 years to 74 years
People
42
Run by
Ankara Medipol University
See details and how to joinNCT07847294
No phaseTaking people
Effect of Stress Ball Applied During Surgical Debridement/Dressing on Pain, Distress, and Physiological Parameters in Patients With Diabetic Foot Ulcers
Where
Mersin
Age
18 years and over
People
84
Run by
Cukurova University
See details and how to joinNCT07119983
No phaseNot yet taking people in Türkiye
Effect of Digital-Supported Foot Care Education in Individuals With Type 2 Diabetes
Where
Siirt
Age
18 years and over
People
90
Run by
Siirt University
See details and how to joinNCT07813676
No phaseNot yet taking people in Türkiye
Digital Self-Management Education and Support for Young Adults With Type 2 Diabetes (DSMESYAT2DM)
Where
Van
Age
18 years to 45 years
People
72
Run by
Recep Turan
See details and how to joinNCT07325838
Phase 3Not yet taking people in Türkiye
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Where
Adana, Ankara, Antalya, Bakırköy, Gaziantep, Kayseri, Yüreğir
Age
18 years and over
People
900 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662135 · EU 2025-523940-12-00
Phase 3Not yet taking people in Türkiye
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Where
Adana, Adana /yüreği̇r, Adapazarı/Turkiye, Afyonkarahisar, Ankara, Gaziantep, Istanbul, Izmir, Kayseri, Kocaeli, Nilüfer/Bursa, Odunpazarı /Eskişehir, Sivas, Sur / Diyarbakır
Age
45 years and over
People
1,778 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07797335